Clinical Trials Logo

Clinical Trial Summary

Alge as a positive control drug, in patients with periarthritis of shoulder, in a double-blind, controlled manner to study the safety and treatment of Sodium Hyaluronate


Clinical Trial Description

Aerzhi as a positive control drug, in patients with periarthritis of shoulder, in a double-blind, controlled manner to study the safety and treatment of Sodium Hyaluronate. Once a week, continuous treatment for 5 weeks ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03365388
Study type Interventional
Source Peking University People's Hospital
Contact Peng Zhang, Doctor
Phone 08601088326550
Email 52956255@qq.com
Status Not yet recruiting
Phase N/A
Start date April 1, 2018
Completion date April 1, 2020

See also
  Status Clinical Trial Phase
Terminated NCT01807962 - Local Injection Under US Control in GTPS. Phase 3